{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:14:19Z","timestamp":1780582459694,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.seizure.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:08:23Z","timestamp":1419293303000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Xiang-qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-tang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-lin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-quan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-yang","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in psychiatric disorders","volume":"74","author":"Reid","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.seizure.2014.12.001_bib0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1176\/appi.ajp.2013.13010006","article-title":"Lamotrigine dosing for pregnant patients with bipolar disorder","volume":"170","author":"Clark","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.seizure.2014.12.001_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-444-52902-2.00017-5","article-title":"Management of painful neuropathies","volume":"115","author":"Brix Finnerup","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2014.12.001_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004630-199601000-00008","article-title":"Experience with toxic epidermal necrolysis treated in a burn center","volume":"17","author":"Yarbrough","year":"1996","journal-title":"J Burn Care Rehabil"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.seizure.2014.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0035","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gepi.20048","article-title":"Heterogeneity testing in meta-analysis of genome searches","volume":"28","author":"Zintzaras","year":"2005","journal-title":"Genet Epidemiol"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","article-title":"Lamotrigine versus placebo in the prophylaxis of migraine with and without aura","volume":"17","author":"Steiner","year":"1997","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1474-4422(10)70131-9","article-title":"Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomized, double-blind, placebo-controlled, parallel-group trial","volume":"9","author":"Kapoor","year":"2010","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0065","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.WNL.0000063304.88470.D9","article-title":"Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial","volume":"60","author":"Simpson","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2014.12.001_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.seizure.2014.12.001_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"issue":"25","key":"10.1016\/j.seizure.2014.12.001_bib0080","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0447.2009.01537.x","article-title":"Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine","volume":"122","author":"van der Loos","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v63n0411","article-title":"Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study","volume":"63","author":"Normann","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00019442-200504000-00006","article-title":"Maintenance treatment outcomes in older patients with bipolar I disorder","volume":"13","author":"Sajatovic","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0920-1211(95)00085-2","article-title":"A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy","volume":"23","author":"Reunanen","year":"1996","journal-title":"Epilepsy Res"},{"issue":"8948","key":"10.1016\/j.seizure.2014.12.001_bib0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.seizure.2014.12.001_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clineuro.2009.12.014","article-title":"Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients","volume":"112","author":"Zeng","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0135","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","article-title":"An active-control trial of lamotrigine monotherapy for partial seizures","volume":"51","author":"Gilliam","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2014.12.001_bib0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1528-1157.1999.tb05562.x","article-title":"Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin","volume":"40","author":"Steiner","year":"1999","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2014.12.001_bib0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1528-1167.2008.01792.x","article-title":"Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy","volume":"50","author":"Labiner","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2014.12.001_bib0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ejpn.2001.0402","article-title":"The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy","volume":"5","author":"Kluger","year":"2001","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2014.12.001_bib0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2010.00836.x","article-title":"Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6)","volume":"12","author":"Licht","year":"2010","journal-title":"Bipolar Disord"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0887-8994(97)00010-6","article-title":"Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy","volume":"16","author":"Farrell","year":"1997","journal-title":"Pediatr Neurol"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1176\/ajp.156.7.1019","article-title":"Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder","volume":"156","author":"Calabrese","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.seizure.2014.12.001_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.09.007","article-title":"Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial","volume":"57","author":"Beghi","year":"2003","journal-title":"Epilepsy Res"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0185","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clineuro.2012.01.019","article-title":"Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy","volume":"114","author":"Wang","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.seizure.2007.01.004","article-title":"Comparative retention rates and long-term tolerability of new antiepileptic drugs","volume":"16","author":"Chung","year":"2007","journal-title":"Seizure"},{"issue":"20","key":"10.1016\/j.seizure.2014.12.001_bib0195","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"68","author":"Arif","year":"2007","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.seizure.2014.12.001_bib0200","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2014.12.001_bib0205","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Influence by gender, age, and learning disability","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2014.12.001_bib0210","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2011.09.003","article-title":"Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis","volume":"34","author":"Mogami","year":"2012","journal-title":"Brain Dev"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pds.1041","article-title":"Adverse reactions of topiramate and lamotrigine in children","volume":"14","author":"Shechter","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.seizure.2014.12.001_bib0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2004.12.001","article-title":"The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood","volume":"14","author":"McDonald","year":"2005","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.seizure.2014.12.001_bib0225","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long-term lamotrigine in epilepsy","volume":"38","author":"Mackay","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2014.12.001_bib0230","first-page":"237","article-title":"Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom","volume":"42","author":"Wong","year":"2001","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0091270004273678","article-title":"The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study","volume":"45","author":"Acharya","year":"2005","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-006-0236-6","article-title":"Use and safety profile of antiepileptic drugs in Italy","volume":"63","author":"Iorio","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0245","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4088\/JCP.08m04563","article-title":"Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program","volume":"70","author":"Lange-Asschenfeldt","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/11536830-000000000-00000","article-title":"Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England","volume":"33","author":"Aurich-Barrera","year":"2010","journal-title":"Drug Saf"},{"issue":"8","key":"10.1016\/j.seizure.2014.12.001_bib0255","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/11591730-000000000-00000","article-title":"Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register","volume":"34","author":"Wallerstedt","year":"2011","journal-title":"Drug Saf"},{"issue":"Suppl. 5","key":"10.1016\/j.seizure.2014.12.001_bib0260","first-page":"S164","article-title":"Skin rash associated with Lamictal: incidence, time to onset and risk factors","volume":"37","author":"Manasco","year":"1996","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2014.12.001_bib0265","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2125.1998.00774.x","article-title":"Prescription-event monitoring recent progress and future horizons","volume":"46","author":"Mann","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0275","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2165\/00002018-200124090-00005","article-title":"Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring","volume":"24","author":"Layton","year":"2001","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.seizure.2014.12.001_bib0280","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1528-1167.2008.01660.x","article-title":"Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests","volume":"49","author":"Aouam","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2014.12.001_bib0285","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2011.02.005","article-title":"Influence of chemical structure on skin reactions induced by antiepileptic drugs \u2013 the role of the aromatic ring","volume":"94","author":"Wang","year":"2011","journal-title":"Epilepsy Res"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131114003124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131114003124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:44:34Z","timestamp":1761011074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131114003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":57,"alternative-id":["S1059131114003124"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2014.12.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}